Lexicon Pharmaceuticals Inc. (LXRX)

7.26
0.17 2.40
NASDAQ : Health Technology
Prev Close 7.09
Open 7.04
Day Low/High 6.98 / 7.43
52 Wk Low/High 6.75 / 13.97
Volume 840.89K
Avg Volume 415.50K
Exchange NASDAQ
Shares Outstanding 105.92M
Market Cap 783.85M
EPS -1.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
Lexicon Pharmaceuticals Enters Oversold Territory (LXRX)

Lexicon Pharmaceuticals Enters Oversold Territory (LXRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting LXRX Put And Call Options For November 16th

Interesting LXRX Put And Call Options For November 16th

Investors in Lexicon Pharmaceuticals, Inc. saw new options become available this week, for the November 16th expiration.

New Insights Revealed In National Survey Show More Advances Are Needed For The Type 1 Diabetes Community

New Insights Revealed In National Survey Show More Advances Are Needed For The Type 1 Diabetes Community

Endocrinologists and Adults with Type 1 Diabetes Struggle to Keep Blood Sugar within Recommended Range Yet Remain Hopeful and Optimistic About the Future of Disease Management

First Week Of January 2019 Options Trading For Lexicon Pharmaceuticals (LXRX)

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading this week, for the January 2019 expiration.

Lexicon Pharmaceuticals To Highlight Pipeline Progress At R&d Day On April 10, 2018

Lexicon Pharmaceuticals To Highlight Pipeline Progress At R&d Day On April 10, 2018

Company to Profile Key Assets Projected to Drive Long-Term Growth

First Week of May 18th Options Trading For Lexicon Pharmaceuticals (LXRX)

First Week of May 18th Options Trading For Lexicon Pharmaceuticals (LXRX)

Investors in Lexicon Pharmaceuticals, Inc. saw new options become available this week, for the May 18th expiration.

Lexicon Pharmaceuticals Becomes Oversold (LXRX)

Lexicon Pharmaceuticals Becomes Oversold (LXRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of LXRX February 2018 Options Trading

First Week of LXRX February 2018 Options Trading

Investors in Lexicon Pharmaceuticals, Inc. saw new options become available this week, for the February 2018 expiration.

First Week Of July 2018 Options Trading For Lexicon Pharmaceuticals (LXRX)

First Week Of July 2018 Options Trading For Lexicon Pharmaceuticals (LXRX)

Investors in Lexicon Pharmaceuticals, Inc. saw new options become available this week, for the July 2018 expiration.

Short Interest Declines 13.8% For LXRX

Short Interest Declines 13.8% For LXRX

The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 2,150,673 share decrease in total short interest for Lexicon Pharmaceuticals, Inc. , to 13,435,509, a decrease of 13.80% since 10/13/2017.

First Week of LXRX December 15th Options Trading

First Week of LXRX December 15th Options Trading

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading this week, for the December 15th expiration.

LXRX: Insiders vs. Shorts

LXRX: Insiders vs. Shorts

The most recent short interest data was recently released for the 08/31/2017 settlement date, and Lexicon Pharmaceuticals, Inc. is one of the most shorted stocks of the Russell 3000, based on 31.32 "days to cover" versus the median component at 6.19.

Biotech Mailbag: Buy Dip in T2 Biosystems?

Biotech Mailbag: Buy Dip in T2 Biosystems?

Plus, what's going on with Lexicon Pharmaceuticals?

Interesting LXRX Put And Call Options For September 15th

Interesting LXRX Put And Call Options For September 15th

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading today, for the September 15th expiration.

Interesting LXRX Put And Call Options For August 18th

Investors in Lexicon Pharmaceuticals, Inc. saw new options become available this week, for the August 18th expiration.

First Week of January 2018 Options Trading For Lexicon Pharmaceuticals (LXRX)

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading this week, for the January 2018 expiration.

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Karyopharm Therapeutics falls 18%; Lexicon rises on drug approval.

4 Smaller Biotech Names Worth Researching

4 Smaller Biotech Names Worth Researching

Here's why to check out Dynavax Technologies as well Lexicon, Supernus and Acadia Pharmaceuticals.

7 Things to Watch in Biotech Now

7 Things to Watch in Biotech Now

M&A, drug approvals and Trump are all on my watch list.

These 3 Biotech Stocks Are Already Moving Wildly on Thursday

These 3 Biotech Stocks Are Already Moving Wildly on Thursday

Here are some names that have caught our eye.

First Week of LXRX February 2017 Options Trading

First Week of LXRX February 2017 Options Trading

Investors in Lexicon Pharmaceuticals, Inc. saw new options begin trading this week, for the February 2017 expiration.

TheStreet Quant Rating: D (Sell)